This Article Full Text Full Text (PDF) All Versions of this Article: 27/4/568    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Anderson, R. A. Articles by Zaneveld, L. J. D. Search for Related Content PubMed PubMed Citation Articles by Anderson, R. A. Articles by Zaneveld, L. J. D.

Journal of Andrology, Vol. 27, No. 4, July/August 2006
Copyright © American Society of Andrology

SAMMA Induces Premature Human Acrosomal Loss by Ca²⁺ Signaling Dysregulation

DONALD P. WALLER

From the Program for the Topical Prevention of Conception and Disease (TOPCAD) and ^* Departments of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois; and the Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois.

Correspondence to: Robert A. Anderson Jr, Ob/Gyn Research, Rush Medical Center, Chicago, IL 60612 (e-mail: randerso{at}rush.edu).

SAMMA is licensed for development as a contraceptive microbicide. Understanding mechanisms of its biological activity is prerequisite to designing more active second generation products. This study examined Ca²⁺ involvement in SAMMA-induced premature acrosomal loss (SAL) in noncapacitated human spermatozoa. SAMMA causes acrosomal loss (AL) in a dose-dependent manner (ED₅₀ = 0.25 µg/mL). SAL requires extracellular Ca²⁺ (ED₅₀ = 85 µM). SAL is inhibited by verapamil (nonspecific voltage-dependent Ca²⁺ channel blocker; IC₅₀ = 0.4 µM), diphenylhydantoin and NiCl₂ (T-type [Ca_v3.x] channel blockers; IC₅₀ 210 µM and 75 µM, respectively). Verapamil blockade of L-type (Ca_v1.x) channels is use-dependent; activated channels are more sensitive to inhibition. However, verapamil inhibition of SAL does not increase after repeated SAMMA stimulation. SAL is unaffected by 10 µM nifedipine (selective L-type channel blocker). This contrasts to 40% inhibition (P < .001) of AL induced by 1 µM thapsigargin (Ca²⁺-ATPase inhibitor; releases intracellular Ca²⁺ stores, promotes capacitative Ca²⁺ entry). SAL is unaffected by 1 µM BAPTA-AM (intracellular Ca²⁺ chelator), and 50 µM 2-APB (blocks InsP3 receptors and store-operated channels). This contrasts with thapsigargin-induced AL, inhibited nearly 65% by BAPTA-AM (P < .005) and 91% by 2-APB (P, .001). The results suggest that SAL is mediated by Ca²⁺ entry through channels pharmacologically similar to the T-type (Ca_v3.2) class. This process appears distinct from that caused by physiological stimuli such as progesterone or zona pellucida-derived proteins. SAMMA's contraceptive activity may be caused by induction of premature AL through dysregulation of Ca²⁺ signaling.

     Key words: Topical contraceptive microbicide, signal transduction, spermatozoa, mechanism, calcium channels